MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities$99,200K Cash and cashequivalents$37,732K Prepaid expenses andother current assets$18,485K Receivable from contractswith collaborators$12,227K Total current assets$167,644K Operating leaseright-of-use assets$4,133K Other assets$408K Property and equipment,net$64K Total assets$172,249K Accumulated deficit-$1,438,938K Accumulated othercomprehensive income (loss)-$5,149K Total liabilities andstockholders' equity...$172,249K Total stockholders'equity (deficit)-$122,760K Additional paid-in capital$1,321,303K Common stock, 0.0001par value...$24K Total liabilities$295,009K Long-term convertiblesenior notes$198,508K Total currentliabilities$63,435K Long-term contractliabilities$29,606K Operating leaseliabilities - long-term$3,460K Accrued research anddevelopment expenses$21,662K Current contractliabilities$19,987K Accrued expenses andother current...$15,827K Accounts payable$5,959K
Balance Sheet
source: myfinsight.com

Gossamer Bio, Inc. (GOSS)

Gossamer Bio, Inc. (GOSS)